Xyosted 50 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZH9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,894
Award facts
- Contract value 100% obligated
- $1,894.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,894.19 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Xyosted 50 mg/0.5 ml auto-injector vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is expected to be fulfilled by January 7, 2026. AmerisourceBergen Drug Corp operates as the subsidiary of Cencora, Inc., which serves as the parent entity in this contracting structure.
This delivery order is issued under an existing Indefinite Delivery Contract (IDC) vehicle between Cencora, Inc. and the DLA Troop Support Medical division, valued at up to $999,999,999.00 through December 31, 2031. This prime IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Xyosted is a testosterone replacement therapy medication commonly used in military and veteran healthcare systems, and this order represents one of numerous task orders issued under the broader pharmaceutical supply agreement that encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F0ZH9?
SPE2DR26F0ZH9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F0ZH9 worth?
The government has obligated $1,894 on SPE2DR26F0ZH9.
Is contract SPE2DR26F0ZH9 an order under another contract?
Yes. SPE2DR26F0ZH9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZH9 competed?
The extent of competition for SPE2DR26F0ZH9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award